Temat: "Retreatment" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Retreatment with HBV siRNA Results in Additional Reduction in HBV Antigenemia and Immune Stimulation in the AAV-HBV Mouse Model.
Autorzy:: Van Gulck E; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Conceição-Neto N; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Aerts L; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Pierson W; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Verschueren L; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Vleeschouwer M; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.
Krishna V; Infectious Diseases and Vaccines, Janssen Research and Development, 1400 McKean Road, Springhouse, PA 19002, USA.
Nájera I; Infectious Diseases and Vaccines, Janssen Research and Development, 1600 Sierra Point Parkway, South San Fransisco, CA 94005, USA.
Pauwels F; Infectious Diseases and Vaccines, Janssen Research and Development, Turnhoutseweg 30, 2340 Beerse, Belgium.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 23; Vol. 16 (3). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Journal Article
MeSH Terms:: Hepatitis B Surface Antigens*
Hepatitis B virus*/genetics
Animals ; Mice ; RNA, Small Interfering/genetics ; Liver ; Retreatment ; DNA, Viral ; Antiviral Agents/therapeutic use ; Membrane Glycoproteins ; Receptors, Immunologic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Influence of larval growth and habitat shading on retreatment frequencies of biolarvicides against malaria vectors.
Autorzy:: Msugupakulya BJ; Environmental Health and Ecological Sciences Department, Ifakara Health Institute, P.O. Box 53, Ifakara, Tanzania. .; Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK. .
Ngajuma SK; Environmental Health and Ecological Sciences Department, Ifakara Health Institute, P.O. Box 53, Ifakara, Tanzania.
Ngayambwa AN; Environmental Health and Ecological Sciences Department, Ifakara Health Institute, P.O. Box 53, Ifakara, Tanzania.
Kidwanga BE; Environmental Health and Ecological Sciences Department, Ifakara Health Institute, P.O. Box 53, Ifakara, Tanzania.
Mpasuka IR; Environmental Health and Ecological Sciences Department, Ifakara Health Institute, P.O. Box 53, Ifakara, Tanzania.
Selvaraj P; Institute for Disease Modeling, Bill and Melinda Gates Foundation, Seattle, USA.; School of Life Science and Bioengineering, The Nelson Mandela African Institution of Sciences & Technology, Arusha, Tanzania.
Wilson AL; Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK.
Okumu FO; Environmental Health and Ecological Sciences Department, Ifakara Health Institute, P.O. Box 53, Ifakara, Tanzania.; School of Life Science and Bioengineering, The Nelson Mandela African Institution of Sciences & Technology, Arusha, Tanzania.; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Park Town, Republic of South Africa.; School of Biodiversity, One Health, and Veterinary Medicine, University of Glasgow, Glasgow, UK.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 10; Vol. 14 (1), pp. 1002. Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Journal Article
MeSH Terms:: Anopheles*
Malaria*/prevention & control
Bacillus thuringiensis*
Animals ; Larva ; Mosquito Vectors ; Retreatment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Retreatment with upadacitinib in atopic dermatitis: experience in clinical practice.
Autorzy:: Martínez-Fernández S; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain.; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Suh-Oh HJ; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain.; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Batalla A; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain.; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Couselo-Rodríguez C; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain.; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Espasandín-Arias M; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain.; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.
Flórez Á; Department of Dermatology, University Hospital of Pontevedra, Pontevedra, Spain.; DIPO Research Group, Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain.; Pokaż więcej
Źródło:: The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2242543.
Typ publikacji:: Journal Article
MeSH Terms:: Dermatitis, Atopic*/drug therapy
Humans ; Heterocyclic Compounds, 3-Ring ; Retreatment ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Does MOSES pulse modulation reduce short-term catheter reinsertion following holmium laser enucleation of the prostate?
Autorzy:: Klett DE; Department of Urology, Mayo Clinic Rochester, Rochester, MN, USA.
Baird B; Department of Urology, Mayo Clinic Florida, Jacksonville, FL, USA.
Ball CT; Department of Biomedical Statistics & Informatics, Mayo Clinic Florida, Jacksonville, FL, USA.
Dora CD; Department of Urology, Mayo Clinic Florida, Jacksonville, FL, USA. .; Pokaż więcej
Źródło:: Investigative and clinical urology [Investig Clin Urol] 2021 Nov; Vol. 62 (6), pp. 666-671.
Typ publikacji:: Journal Article
MeSH Terms:: Laser Therapy*/adverse effects
Laser Therapy*/methods
Postoperative Complications*/etiology
Postoperative Complications*/therapy
Prostatectomy*/adverse effects
Prostatectomy*/instrumentation
Prostatectomy*/methods
Retreatment*/methods
Retreatment*/statistics & numerical data
Urinary Catheterization*/methods
Urinary Catheterization*/statistics & numerical data
Prostatic Hyperplasia/*surgery
Aged ; Comparative Effectiveness Research ; Holmium/therapeutic use ; Humans ; Male ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/statistics & numerical data ; Prostate/pathology ; Prostate/surgery ; Urinary Catheters

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Disease progression status during initial immune checkpoint inhibitor (ICI) affects the clinical outcome of ICI retreatment in advanced non-small cell lung cancer patients.
Autorzy:: Torasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
Takeyasu Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Shimoda Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Tateishi A; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Matsumoto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Masuda K; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Yamamoto N; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
Takahashi K; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Jun; Vol. 12 (11), pp. 12388-12401. Date of Electronic Publication: 2023 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*/drug therapy
Antineoplastic Agents, Immunological*/adverse effects
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Retrospective Studies ; Retreatment ; Disease Progression

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Retreatment of oval-shaped root canals filled with TotalFill bioceramic or AH plus sealer.
Autorzy:: Jamleh A; Restorative and Prosthetic Dental Sciences, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, P.O. Box 22490, 11426, Riyadh, Kingdom of Saudi Arabia. .; King Abdullah International Medical Research Centre, National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia. .
Nassar M; Department of Preventive and Restorative Dentistry, College of Dental Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Alfadley A; Restorative and Prosthetic Dental Sciences, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, P.O. Box 22490, 11426, Riyadh, Kingdom of Saudi Arabia.; King Abdullah International Medical Research Centre, National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Alanazi A; Restorative and Prosthetic Dental Sciences, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, P.O. Box 22490, 11426, Riyadh, Kingdom of Saudi Arabia.; Endodontic Division, Dental Services, Central Region, King Abdulaziz Medical City, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Alotiabi H; Restorative and Prosthetic Dental Sciences, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, P.O. Box 22490, 11426, Riyadh, Kingdom of Saudi Arabia.; King Abdullah International Medical Research Centre, National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Alghilan M; Restorative and Prosthetic Dental Sciences, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, P.O. Box 22490, 11426, Riyadh, Kingdom of Saudi Arabia.; King Abdullah International Medical Research Centre, National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.
Alfouzan K; Restorative and Prosthetic Dental Sciences, College of Dentistry, King Saud bin Abdulaziz University for Health Sciences, National Guard Health Affairs, P.O. Box 22490, 11426, Riyadh, Kingdom of Saudi Arabia.; King Abdullah International Medical Research Centre, National Guard Health Affairs, Riyadh, Kingdom of Saudi Arabia.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Jun 08; Vol. 13 (1), pp. 9357. Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:: Journal Article
MeSH Terms:: Dental Pulp Cavity*
Root Canal Obturation*/methods
X-Ray Microtomography ; Root Canal Preparation/methods ; Gutta-Percha ; Retreatment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Outcomes of alpha-blockers as medical expulsive therapy following shockwave lithotripsy: a systematic review and meta-analysis.
Autorzy:: Brain E; Newcastle Medical School, Newcastle University, Newcastle-upon-Tyne, UK.
Geraghty RM; Department of Urology, Freeman Hospital, Newcastle-upon-Tyne, UK.; Institute of Genetic Medicine, Newcastle University, Newcastle-upon-Tyne, UK.
Tzelves L; Department of Urology, National and Kapodistrian University of Athens, Sismanogleio Hospital, Athens, Greece.
Mourmouris P; Department of Urology, National and Kapodistrian University of Athens, Sismanogleio Hospital, Athens, Greece.
Chatzikrachtis N; Department of Urology, National and Kapodistrian University of Athens, Sismanogleio Hospital, Athens, Greece.
Karavitakis M; Department of Urology, National and Kapodistrian University of Athens, Sismanogleio Hospital, Athens, Greece.
Skolarikos A; Department of Urology, National and Kapodistrian University of Athens, Sismanogleio Hospital, Athens, Greece.
Somani BK; Department of Urology, University Hospital Southampton, Southampton, UK.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2023 Apr; Vol. 131 (4), pp. 424-433. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Ureteral Calculi*/therapy
Lithotripsy*/adverse effects
Lithotripsy*/methods
Humans ; Adult ; Middle Aged ; Adrenergic alpha-Antagonists/therapeutic use ; Retreatment ; Pain

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Protocol for pragmatic randomized clinical trial to evaluate the completion of treatment of latent Mycobacterium tuberculosis infection with Isoniazid in the 300 mg formulation.
Autorzy:: Cola JP; Postgraduate Program in Collective Health, Laboratory of Epidemiology, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.
Prado TND; Postgraduate Program in Collective Health, Laboratory of Epidemiology, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.
Campos BA; Postgraduate Program in Collective Health, Laboratory of Epidemiology, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.
Borges BJP; Postgraduate Program in Collective Health, Laboratory of Epidemiology, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.
Alves BMCS; Postgraduate Program in Pharmaceutical Sciences, Universidade de Brasília, Brasília, Distrito Federal, Brazil.
Jezus SV; Postgraduate Program in Collective Health, Laboratory of Epidemiology, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.
Sales CMM; Postgraduate Program in Collective Health, Laboratory of Epidemiology, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.
Araújo WN; Postgraduate Program in Tropical Medicine, Universidade de Brasília, Brasília, Distrito Federal, Brazil.
Tavares NUL; Postgraduate Program in Pharmaceutical Sciences, Universidade de Brasília, Brasília, Distrito Federal, Brazil.
Noia Maciel EL; Postgraduate Program in Collective Health, Laboratory of Epidemiology, Universidade Federal do Espírito Santo, Vitória, Espírito Santo, Brazil.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Feb 21; Vol. 18 (2), pp. e0281638. Date of Electronic Publication: 2023 Feb 21 (Print Publication: 2023).
Typ publikacji:: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Isoniazid*
Latent Tuberculosis*/drug therapy
Humans ; Adolescent ; Adult ; Antitubercular Agents ; Retreatment ; Brazil ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Microcomputed tomographic analysis of the efficiency of two retreatment techniques in removing root canal filling materials from mandibular incisors.
Autorzy:: Yang X; State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Wang Y; State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Ji M; State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Li Y; State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Wang H; State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China.
Luo T; Department of Stomatology, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610041, China.
Gao Y; State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China. .
Zou L; State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Feb 08; Vol. 13 (1), pp. 2267. Date of Electronic Publication: 2023 Feb 08.
Typ publikacji:: Journal Article
MeSH Terms:: Root Canal Filling Materials*/therapeutic use
Humans ; X-Ray Microtomography/methods ; Gutta-Percha ; Chloroform ; Incisor/diagnostic imaging ; Root Canal Preparation ; Root Canal Obturation/methods ; Equipment Design ; Retreatment ; Titanium

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A prospective, randomized, phase II study to assess the schemas of retreatment with Lutathera® in patients with new progression of an intestinal, well-differentiated neuroendocrine tumor (ReLUTH).
Autorzy:: Deshayes E; Nuclear Medicine Department, Montpellier Cancer Institute (ICM), University of Montpellier, 208 Avenue des Apothicaires, 34298, Montpellier, France. .; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University of Montpellier, Montpellier, France. .
Assenat E; Medical Oncology Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; Medical Oncology Department, CHU Montpellier, University of Montpellier, Montpellier, France.
Meignant L; Clinical Research and Innovation Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.
Bardiès M; Nuclear Medicine Department, Montpellier Cancer Institute (ICM), University of Montpellier, 208 Avenue des Apothicaires, 34298, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University of Montpellier, Montpellier, France.
Santoro L; Nuclear Medicine Department, Montpellier Cancer Institute (ICM), University of Montpellier, 208 Avenue des Apothicaires, 34298, Montpellier, France.; Institut de Recherche en Cancérologie de Montpellier (IRCM), INSERM U1194, University of Montpellier, Montpellier, France.
Gourgou S; Biometrics Unit, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2022 Dec 22; Vol. 22 (1), pp. 1346. Date of Electronic Publication: 2022 Dec 22.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article
MeSH Terms:: Neuroendocrine Tumors*/pathology
Organometallic Compounds*/adverse effects
Humans ; Quality of Life ; Prospective Studies ; Octreotide ; Retreatment
SCR Disease Name:: Gastro-enteropancreatic neuroendocrine tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Treatment with CoreTherm in 570 patients with prostate volumes of 80-366 ml: an evaluation of short- and long-term retreatment risk.
Autorzy:: Stenmark F; Department of Urology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Department of Urology, Kalmar County Hospital, Kalmar, Sweden.
Brudin L; Department of Medicine and Health Sciences, University Hospital in Linköping, Linköping, Sweden.; Department of Clinical Physiology, Kalmar County Hospital, Kalmar, Sweden.
Kjölhede H; Department of Urology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Peeker R; Department of Urology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.
Stranne J; Department of Urology, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Göteborg, Sweden.; Pokaż więcej
Źródło:: Scandinavian journal of urology [Scand J Urol] 2022 Aug; Vol. 56 (4), pp. 336-341. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:: Journal Article
MeSH Terms:: Prostatic Hyperplasia*/surgery
Prostatic Hyperplasia*/therapy
Transurethral Resection of Prostate*/methods
Urinary Retention*/surgery
Urinary Retention*/therapy
Epinephrine ; Humans ; Male ; Mepivacaine ; Prostate ; Retreatment ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Evaluation of changes in root canal length and accuracy of the electronic apex locator during different stages of endodontic treatment and retreatment
Autorzy:: Cardoso, Ihan Vitor
Silveira, Matheus Pompeo Caldas
Vitali, Filipe Colombo
Piasecki, Lucila
da Fonseca Roberti Garcia, Lucas
Bortoluzzi, Eduardo Antunes
Teixeira, Cleonice SilveiraAff1, IDs10266023008465_cor7; Pokaż więcej
Źródło:: Odontology: Official Journal of the Society of the Nippon Dental University. 112(2):537-545

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 13.

Tytuł:: Efficacy and safety of intravenous immunoglobulin retreatment amongst Guillain–Barré syndrome patients who poorly responded to initial IVIG cycle: a systematic review
Autorzy:: Prado, Jr., Mario B.Aff1, IDs13760024025189_cor1
Adiao, Karen Joy B.
Turalde, Christian Wilson R.
Dasig, Darwin A.; Pokaż więcej
Źródło:: Acta Neurologica Belgica. :1-14

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 14.

Tytuł:: Retreatment with nivolumab for patients with recurrent and/or metastatic head and neck cancer.
Autorzy:: Wakasugi T; Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Takeuchi S; Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Ohkubo JI; Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.
Suzuki H; Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.; Pokaż więcej
Źródło:: Acta oto-laryngologica [Acta Otolaryngol] 2022 Feb; Vol. 142 (2), pp. 206-212. Date of Electronic Publication: 2022 Feb 11.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents, Immunological*/adverse effects
Antineoplastic Agents, Immunological*/therapeutic use
Head and Neck Neoplasms*/drug therapy
Humans ; Neoplasm Recurrence, Local/drug therapy ; Nivolumab/adverse effects ; Nivolumab/therapeutic use ; Retreatment ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Multicentric, multifocal, and recurrent osteoid osteoma of the hip: first case report.
Autorzy:: Cortese MC; Istituto di Radiologia, F. Policlinico Gemelli - IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Albano D; Università degli Studi di Palermo, Dipartimento di Biomedicina, Neuroscienze e Diagnostica Avanzata, Palermo, Italy. .
Messina C; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.; IRCCS Istituto Ortopedico Galeazzi, Milano, Italy.
Perrucchini G; Ortopedia Oncologica, Fondazione Istituto San Raffaele Giglio, Cefalù, Italy.
Gallazzi E; Università degli Studi di Milano, Scuola di Specializzazione in Ortopedia, Milan, Italy.
Gallazzi MB; Struttura Complessa di Radiologia, Azienda Sociosanitaria Territoriale PINI-CTO, Milan, Italy.
Daolio PA; Struttura Complessa di Ortopedia Oncologica, Azienda Sociosanitaria Territoriale PINI-CTO, Milan, Italy.
Sconfienza LM; Dipartimento di Scienze Biomediche per la Salute, Università degli Studi di Milano, Milan, Italy.; IRCCS Istituto Ortopedico Galeazzi, Milano, Italy.; Pokaż więcej
Źródło:: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2019 Apr 16; Vol. 20 (1), pp. 171. Date of Electronic Publication: 2019 Apr 16.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Radiofrequency Ablation*
Retreatment*
Bone Neoplasms/*surgery
Neoplasm Recurrence, Local/*surgery
Osteoma, Osteoid/*surgery
Acetabulum/diagnostic imaging ; Acetabulum/pathology ; Acetabulum/surgery ; Adult ; Biopsy ; Bone Neoplasms/diagnosis ; Bone Neoplasms/pathology ; Femur Neck/diagnostic imaging ; Femur Neck/pathology ; Femur Neck/surgery ; Humans ; Magnetic Resonance Imaging ; Male ; Neoplasm Recurrence, Local/diagnosis ; Neoplasm Recurrence, Local/pathology ; Osteoma, Osteoid/diagnosis ; Osteoma, Osteoid/pathology ; Tomography, X-Ray Computed ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Neurotoxicity and safety of the rechallenge of immune checkpoint inhibitors: a growing issue in neuro-oncology practice.
Autorzy:: Villagrán-García M; Neuro-Oncology Unit, Neurology Department, Hospital Universitari de Bellvitge-Institut Català d Oncologia L'Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, C/Feixa Llarga S/N, 08907, L'Hospitalet, Barcelona, Spain.
Velasco R; Neuro-Oncology Unit, Neurology Department, Hospital Universitari de Bellvitge-Institut Català d Oncologia L'Hospitalet, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, C/Feixa Llarga S/N, 08907, L'Hospitalet, Barcelona, Spain. .; Institute of Neurosciences and Department of Cell Biology, Physiology and Immunology, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Bellaterra, Spain. .; Pokaż więcej
Źródło:: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Apr; Vol. 43 (4), pp. 2339-2361. Date of Electronic Publication: 2022 Feb 17.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Neoplasms*/drug therapy
Neurotoxicity Syndromes*/drug therapy
Humans ; Immune Checkpoint Inhibitors/adverse effects ; Peripheral Nervous System ; Retreatment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Secukinumab retreatment associated psoriasis flare with pustules.
Autorzy:: El-Komy M; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Amer M; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Mostafa A; Department of Dermatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Department of Dermatology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
ElKalioby M; Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.; Pokaż więcej
Źródło:: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Mar; Vol. 33 (2), pp. 1107-1110. Date of Electronic Publication: 2020 Jun 19.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Arthritis, Psoriatic*/complications
Arthritis, Psoriatic*/drug therapy
Psoriasis*/drug therapy
Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Retreatment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Pomalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of the non-interventional study POSEIDON and comparison with the pivotal phase 3 clinical trials.
Autorzy:: Dechow T; Onkologie Ravensburg, Ravensburg, Germany.
Aldaoud A; Gemeinschaftspraxis für Hämatologie & Onkologie, Leipzig, Germany.
Behlendorf T; Gemeinschaftspraxis für Innere Medizin, Hämatologie & Onkologie, Halle (Saale), Germany.
Knauf W; Centrum für Hämatologie und Onkologie Bethanien, Frankfurt am Main, Germany.
Eschenburg H; Internistische Gemeinschaftspraxis, Güstrow, Germany.
Groschek M; Praxis für Hämatologie und Onkologie, Stolberg, Germany.
Hansen R; Schwerpunktpraxis für Hämatologie und Onkologie, Kaiserlautern, Germany.
Söling U; Hämato-onkologisches Zentrum Kassel GmbH, Kassel, Germany.
Grebhardt S; iOMEDICO, Freiburg im Breisgau, Germany.
Siebenbach HU; iOMEDICO, Freiburg im Breisgau, Germany.
Vannier C; iOMEDICO, Freiburg im Breisgau, Germany.
Potthoff K; iOMEDICO, Freiburg im Breisgau, Germany.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2022 Feb; Vol. 108 (2), pp. 133-144. Date of Electronic Publication: 2021 Nov 15.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*drug therapy
Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dexamethasone ; Disease Management ; Drug Resistance, Neoplasm ; Female ; Follow-Up Studies ; Humans ; Lenalidomide ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Quality of Life ; Recurrence ; Retreatment ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: End of treatment FDG-PET in primary mediastinal B-cell lymphoma treated with R-chemotherapy: Prognostic indicator and implications for consolidation radiotherapy.
Autorzy:: Freitas AC; Hematology Department, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal.
Carvalho IP; Nuclear Medicine Department, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal.
Esteves S; Clinical Research Unit, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal.
Salgado L; Nuclear Medicine Department, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal.
Gomes da Silva M; Hematology Department, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal.; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2022 Feb; Vol. 108 (2), pp. 118-124. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji:: Journal Article
MeSH Terms:: Fluorodeoxyglucose F18*
Positron-Emission Tomography*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Lymphoma, B-Cell/*diagnosis
Lymphoma, B-Cell/*drug therapy
Mediastinal Neoplasms/*diagnosis
Mediastinal Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Clinical Decision-Making ; Combined Modality Therapy ; Cyclophosphamide/adverse effects ; Cyclophosphamide/therapeutic use ; Disease Management ; Doxorubicin/adverse effects ; Doxorubicin/therapeutic use ; Female ; Humans ; Lymphoma, B-Cell/mortality ; Male ; Mediastinal Neoplasms/mortality ; Middle Aged ; Prednisone/adverse effects ; Prednisone/therapeutic use ; Prognosis ; Retreatment ; Rituximab/adverse effects ; Rituximab/therapeutic use ; Treatment Outcome ; Vincristine/adverse effects ; Vincristine/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Sofosbuvir/velpatasvir/voxilaprevir for hepatitis C virus retreatment in decompensated cirrhosis.
Autorzy:: Patel S; Specialty Pharmacy, Northwestern Medicine, Chicago, Illinois, USA.
Martin MT; Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, Illinois, USA.; Liver Clinic, University of Illinois Hospital and Health Sciences System, Chicago, Illinois, USA.
Flamm SL; Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois, USA.; Pokaż więcej
Źródło:: Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2021 Dec; Vol. 41 (12), pp. 3024-3027. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Sofosbuvir*/therapeutic use
Aminoisobutyric Acids ; Antiviral Agents/therapeutic use ; Carbamates ; Cyclopropanes ; Drug Therapy, Combination ; Genotype ; Hepacivirus/genetics ; Heterocyclic Compounds, 4 or More Rings/therapeutic use ; Humans ; Lactams, Macrocyclic ; Leucine/analogs & derivatives ; Liver Cirrhosis/drug therapy ; Proline/analogs & derivatives ; Quinoxalines ; Retreatment ; Sulfonamides

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Retreatment"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język